The hysterosalpingogram (HSG) is a radiological procedure that evaluates tubal patency and uterine cavity morphology — two variables that profoundly affect ICI success. For many ICI candidates, the question of whether to obtain an HSG before starting cycles or only after multiple failures is one of the most consequential protocol decisions they will make.
What an HSG Evaluates
An HSG is performed by injecting radiopaque contrast dye through the cervix into the uterine cavity under fluoroscopic (real-time X-ray) guidance, then observing the dye’s path through the fallopian tubes. A normal HSG shows: a triangular uterine cavity without filling defects (which would suggest polyps, fibroids, adhesions, or other intrauterine pathology), bilateral free spill of contrast through both fallopian tubes into the peritoneal cavity (confirming tubal patency), and symmetric tube morphology. Abnormal findings include: unilateral or bilateral tubal occlusion, hydrosalpinx (fluid-filled dilated tube), cornual occlusion, uterine filling defects, or cavity distortion from structural abnormalities.
The clinical significance of HSG findings for ICI is straightforward: ICI depends on sperm traveling through the fallopian tubes to encounter an egg in the ampullary segment. Bilateral tubal occlusion makes ICI biologically impossible, not improbable — without patent tubes, fertilization cannot occur regardless of timing, sperm quality, or procedure technique. Unilateral occlusion reduces effective cycle probability (only one tube can achieve fertilization) but does not preclude ICI. Uterine cavity abnormalities may impair implantation even when tubes are patent. For ICI candidates, an HSG before beginning cycles is the most definitive way to confirm that the biological pathway for ICI success exists.
When to Get an HSG Before ICI
Clinical guidelines recommend HSG evaluation before ICI (or at least before continuing beyond two to three failed ICI cycles) for women with: a history of pelvic inflammatory disease (PID), prior ectopic pregnancy, previous pelvic or abdominal surgery (appendectomy, fibroid removal, ovarian cystectomy), endometriosis (particularly moderate-severe), prior chlamydial or gonorrheal infection even if adequately treated, and women over 38 (for whom the cost of wasted ICI cycles on occluded tubes is particularly high). For young, low-risk women under 32 with no history of pelvic pathology attempting their first ICI cycles, deferring HSG until after three to four failed cycles is a reasonable and commonly practiced approach.
The argument for pre-ICI HSG in all candidates is efficiency — discovering tubal occlusion after six failed cycles is far more expensive and emotionally costly than discovering it before cycle one. The counterargument is procedural burden and cost: HSG involves a clinical visit, modest radiation exposure, the discomfort of the procedure itself (often described as severe cramping), and a cost of $500–$1,500 depending on whether it is performed in a radiology center or clinic and what insurance covers. The individual decision should weigh personal risk history against the cost of proceeding without this information.
What HSG Results Mean for Your Protocol
Normal bilateral tubal patency on HSG clears the anatomical pathway for ICI and confirms the physical mechanism for natural conception is intact. This is important not just for ICI planning but for reassurance — knowing tubes are open and the uterine cavity is normal eliminates two significant variables from the differential diagnosis of unexplained infertility. Some HSG studies have shown a mild ‘therapeutic effect’ in the month or two following the procedure, possibly from mechanical clearing of the tubes or immunological modulation from contrast exposure, though this finding is inconsistent across studies.
Bilateral occlusion on HSG is a definitive finding that indicates ICI cannot be expected to work and IVF is the appropriate pathway. Unilateral occlusion warrants continued ICI with understanding of reduced per-cycle probability, and often prompts consideration of a monitored cycle to confirm which ovary is releasing eggs each month — aligning ICI timing with the ovary attached to the patent tube. Uterine filling defects found on HSG require further evaluation (typically hysteroscopy) before ICI is continued, because intrauterine pathology impairs implantation in ways that perfectly timed ICI cannot overcome. The HSG finding directs you to the right next step rather than leaving you cycling without direction.
Alternatives to HSG for Uterine and Tubal Assessment
For patients who cannot tolerate HSG (severe cervical stenosis, significant contrast allergy, or extreme procedural anxiety), alternative imaging options exist. Hysterosalpingo-contrast sonography (HyCoSy) uses ultrasound with saline or air-based contrast to evaluate tubal patency and uterine cavity without radiation, and is performed transvaginally in a gynecology or reproductive endocrinology office. HyCoSy is less diagnostically complete than fluoroscopic HSG for detailed tubal morphology but is equivalent for detecting occlusion and uterine cavity abnormalities, and is generally better tolerated with less cramping.
Saline infusion sonography (SIS or sonohysterogram) evaluates the uterine cavity with saline contrast under ultrasound but does not assess tubal patency. It is the preferred method for detailed intrauterine cavity evaluation when a filling defect is suspected — it distinguishes submucosal fibroids from endometrial polyps more precisely than HSG. For a comprehensive pre-ICI assessment, many reproductive endocrinologists will perform SIS to evaluate the cavity and HyCoSy or HSG for tubal patency as complementary procedures. The choice depends on clinical history, risk profile, and practitioner availability.
For a complete at-home insemination solution, the MakeAmom Babymaker Kit includes everything you need for a properly timed, sterile ICI cycle.
Further reading across our network: IntracervicalInsemination.org · MakeAmom.com
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making decisions about your fertility care.
